Syeda Hamadani
Allergy & Immunology · Lawrenceville, GANPI 1710246848
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Kaleo, Inc. accounts for 61.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2020 at $3,299 and has fallen 96.7% since, to $109 in 2022.
Across 116 payments — averaging $50.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kaleo, Inc.$4K
- AstraZeneca$529
- GSK$312
- Biocryst US Sales Co., LLC$214
- Boehringer Ingelheim$159
- CSL Behring$128
- plus $905 from 18 others
What the payments were for
- Speaking & faculty fees$3,50060%
- Travel & lodging$521%
- Food & beverage$2,26339%
- Education$401%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kaleo, Inc. | 11 | $3,611 |
| AstraZeneca | 24 | $529 |
| GSK | 18 | $312 |
| Biocryst US Sales Co., LLC | 5 | $214 |
| Boehringer Ingelheim | 8 | $159 |
| CSL Behring | 5 | $128 |
| Octapharma USA, Inc. | 1 | $103 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| Novartis | 6 | $88 |
| Amgen(2 entities) | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Mylan Specialty L.p. | 4 | $71 |
| Grifols USA, LLC | 4 | $64 |
| Pfizer | 4 | $59 |
| Shire North American Group Inc | 3 | $42 |
| Genentech, Inc. | 1 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| Genentech USA, Inc. | 2 | $33 |
| Sanofi | 2 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Mallinckrodt Enterprises LLC | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUVI-Q$3,500
- BREZTRI AEROSPHERE$125
- Orladeyo$124
- CUTAQUIG$103
How this compares
$5,855 in reported general payments places this provider in the 55th percentile of 107 allergy & immunology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $52,639 |
| BreynaBudesonide/Formoterol Fumarate | 31 | $17,338 |
| Spiriva RespimatTiotropium Bromide | 23 | $10,338 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $2,483 |
| AlvescoCiclesonide | 12 | $2,470 |
| Ipratropium Bromide | 63 | $1,562 |
| Azelastine Hcl | 81 | $1,551 |
| Montelukast Sodium | 29 | $318 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $240 |
| Prednisone | 16 | $108 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimSpiriva Respimat | $159 | $10,33823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 107 allergy & immunology providers in Georgia.
Other allergy & immunology in Lawrenceville
- Poneh HeineLawrenceville$14K
- Byol ShinLawrenceville$12K
- Michael BlaissRoswell$1.1M
- Deborah BirxAtlanta$470K
- Tracy BridgesAlbany$364K
- Jack EadesMacon$237K
- Stanley FinemanMarietta$186K
- Robert CartwrightColumbus$169K
- Robert ChrzanowskiColumbus$115K
- Belinda GrahamSmyrna$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.